New era of gene-based 'personalized medicine' dawning

Jun 14, 2009 By Robert S. Boyd, McClatchy Newspapers

Six years ago, scientists announced the completion of the Human Genome Project, a historic effort to decipher each of the 3 billion letters in the genetic instruction book for our species. A single anonymous male from Buffalo, N.Y. - code name RP11 - provided the bulk of the DNA used for the project.

Now, many thousands more people are contributing DNA samples for a wide array of follow-on studies designed to turn the project's findings to practical use in health care, genetics and biological research.

Researchers and doctors have opened a new era of "personalized medicine" that seeks to tailor therapies to patients based on their unique genetic makeups and medical histories.

According to the National Cancer Institute, the days are passing when most were thought to be essentially the same and patients got the same drugs.

"We're not very good at selecting therapies for individual patients," Dr. Rick Hockett, the chief medical officer of Affymetrix, a genetics firm in Santa Clara, Calif., told a conference on personalized medicine this month in Washington. "Targeted therapy," he said, can "improve the benefit-risk ratio for patients."

For example, Hockett said that heart patients who took the popular anti-clotting drug Plavix had a greatly increased risk of serious problems, including death, if they had two tiny mutations in their genes.

Massachusetts General Hospital in Boston and the Memorial Sloan-Kettering Cancer Center in New York have begun to screen lung tumors for genetic abnormalities that could reveal whether a particular treatment is likely to work or should be avoided.

Last year, Dr. Richard Wilson, the director of the Genome Sequencing Center at Washington University in St. Louis, compared 20,000 genes in cancer cells from a woman who died of leukemia with healthy cells also taken from her body. Wilson identified 10 mutations _ or genetic mistakes _ related to her cancer, including one that blocks from getting inside the cancerous cell.

Other developments in the approaching world of personalized medicine include:

_A "Personal Genome Project" led by George Church, a geneticist at Harvard Medical School in Boston, aims to recruit 100,000 people of diverse backgrounds to analyze their genomes and medical histories.

The first 10 participants already have published their personal data _ including their pictures, weights and smoking and drinking habits, as well as their DNA _ on the Internet for anyone to see at www.personalgenomes.org/pgp10.html.

To take part, volunteers donate hair and saliva samples for DNA analysis. So far, 13,000 people have asked to be enrolled. For privacy, their data will be encoded by number, not by individual names.

The goal is to discover which genetic variations are related to which diseases, so that targeted therapies can be designed. According to Church, at least 1,449 genes have been linked to potential illnesses. For instance, a gene called ApoE is associated with a higher risk of Alzheimer's.

_The National Research Institute in Bethesda, Md., has launched a "1000 Genomes Project," which has started to collect DNA from 1,000 individuals from Africa, Asia and Europe. The goal is to provide much broader and deeper information than the original, limited Human Genome Project could.

Researchers are seeking clues to individual differences in susceptibility to disease, response to drugs and sensitivity to the environment.

"Just as astronomers see farther and more clearly into the universe with bigger telescopes, the results of the 1000 Genomes Project will give us greater resolution as we view our own genetic blueprint," Francis Collins, the former director of the National Human Genome Research Institute, said in a statement explaining the plan. "We'll be able to see more things more clearly than before, and that will be important for understanding the genetic contributions to health and illness."

_The National Geographic Society is collecting DNA from about 300,000 people for a "Genographic Project" that traces their distant ancestries from continent to continent all the way back to their African roots.

Researchers at 10 centers around the world collect DNA samples from local populations. A team led by Spencer Wells, a genetic anthropologist and the magazine's "explorer in residence" in Washington, will analyze the samples.

In addition, anyone who wishes to can buy a $100 self-testing kit and provide a saliva sample to the Genographic project. Participants will get back reports that describe in general terms the migration of their ancestors from their original roots in Africa some 60,000 years ago.

_A booming, but controversial, genetic testing industry also has sprouted, offering to analyze a person's DNA _ at a price _ for possible susceptibility to cancer, Alzheimer's and dozens of other diseases.

More than 1,000 such tests are on the market, Kathy Hudson, the director of the Genetics and Public Policy Center at Johns Hopkins University in Washington, told a congressional committee.

According to the Human Genome Project's Web site, some genetic tests have "greatly improved or even saved lives," but there are concerns that they might be used by insurance companies to deny coverage or by employers deciding whom to hire or promote.

To meet these concerns, Congress passed a "Genetic Information Non-Discrimination Act" last year, which is just starting to have an impact.

"The portions of it relating to health insurance just went into effect on May 21, and so will apply to next year's (health) plan for most people," said Susannah Baruch, of the Genetics and Public Policy Center. The parts of the new law that relate to the use of genetic information on the job won't take effect until Nov. 21, but the Equal Employment Opportunity Commission already has drafted regulations.

More on personalized medicine: www.personalizedmedicinecoalition.org

Personal : http://www.personalgenomes.org

1000 Genomes Project: www.1000genomes.org/page.php

National Geographic's Genographic Project: genographic.nationalgeographic.com

___

(c) 2009, McClatchy-Tribune Information Services.

Visit the McClatchy Washington Bureau on the World Wide Web at www.mcclatchydc.com.

Explore further: A nucleotide change could initiate fragile X syndrome

add to favorites email to friend print save as pdf

Related Stories

Johns Hopkins to participate in 1000 Genomes Project

Jan 22, 2008

Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing ...

3 sequencing companies join 1000 Genomes Project

Jun 11, 2008

Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic ...

Researchers ID gene linked to lung cancer

Apr 02, 2008

Researchers at Johns Hopkins, as part of a large, multi-institutional study, have found one gene variant that is linked to an increased risk of lung cancer. The study will be published in the April 3 issue of Nature Genetics.

Cancer patient genome sequenced for the first time

Nov 05, 2008

For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. A large research team at the Genome Sequencing Center ...

Recommended for you

A nucleotide change could initiate fragile X syndrome

17 hours ago

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

Mutation disables innate immune system

Aug 29, 2014

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that ...

Study identifies genetic change in autism-related gene

Aug 28, 2014

A new study from Bradley Hospital has identified a genetic change in a recently identified autism-associated gene, which may provide further insight into the causes of autism. The study, now published online in the Journal of ...

NIH issues finalized policy on genomic data sharing

Aug 27, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jun 14, 2009
What with great microscopes and very smart doctors and scientists and "The Genome" a household word, wouldn't you think a "description" or a "picture" of a "gene" and, or, its parts would be useful? Even "The Atom" can now be visualized!